In this study, the incidence of aortic aneurysm was 86.7% (13/15) with Ang II induction, but was significantly decreased with si-RELMβ treatment (35.7%, 5/14) (P <0.05, Figure 1A and 1B). The gene discussed is RETNLB; the disease is aortic aneurysm.